ANTI-N3PGLU AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF
The invention is directed to a short term induction treatment with anti-N3pGlu Aβ antibodies of a disease characterized by deposition of Aβ in the brain, that include Alzheimer's disease (AD), Down's syndrome, and cerebral amyloid angiopathy (CAA). In certain embodiments, patients are admi...
Saved in:
| Main Authors | , |
|---|---|
| Format | Patent |
| Language | English French German |
| Published |
19.07.2023
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The invention is directed to a short term induction treatment with anti-N3pGlu Aβ antibodies of a disease characterized by deposition of Aβ in the brain, that include Alzheimer's disease (AD), Down's syndrome, and cerebral amyloid angiopathy (CAA). In certain embodiments, patients are administered an induction dose of 10 to 60 mg/kg of an anti-N3pGlu Aβ antibody for a period of 6 months or less. |
|---|---|
| AbstractList | The invention is directed to a short term induction treatment with anti-N3pGlu Aβ antibodies of a disease characterized by deposition of Aβ in the brain, that include Alzheimer's disease (AD), Down's syndrome, and cerebral amyloid angiopathy (CAA). In certain embodiments, patients are administered an induction dose of 10 to 60 mg/kg of an anti-N3pGlu Aβ antibody for a period of 6 months or less. |
| Author | IRIZARRY, Michael Carl DEMATTOS, Ronald Bradley |
| Author_xml | – fullname: IRIZARRY, Michael Carl – fullname: DEMATTOS, Ronald Bradley |
| BookMark | eNrjYmDJy89L5WSwcfQL8dT1Mw5w9wlVcPSN9PH3dFFwcg1xVAhwDQjxdHFVAClw8nfxdA0GMl0UQoOBjBAP1yBXfzceBta0xJziVF4ozc2g4OYa4uyhm1qQH59aXJCYnJqXWhLvGmBsYm5hbmjkZGhMhBIAodcqtQ |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | ANTICORPS ANTI-PEPTIDE BÊTA-AMYLOÏDE N3PGLU ET LEURS UTILISATIONS ANTI-N3PGLU AMYLOID BETA PEPTID ANTIKÖRPER UND DEREN VERWENDUNG |
| ExternalDocumentID | EP3478712B1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_EP3478712B13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Sep 20 10:17:05 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English French German |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_EP3478712B13 |
| Notes | Application Number: EP20170736841 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230719&DB=EPODOC&CC=EP&NR=3478712B1 |
| ParticipantIDs | epo_espacenet_EP3478712B1 |
| PublicationCentury | 2000 |
| PublicationDate | 20230719 |
| PublicationDateYYYYMMDD | 2023-07-19 |
| PublicationDate_xml | – month: 07 year: 2023 text: 20230719 day: 19 |
| PublicationDecade | 2020 |
| PublicationYear | 2023 |
| RelatedCompanies | Eli Lilly and Company |
| RelatedCompanies_xml | – name: Eli Lilly and Company |
| Score | 3.4884644 |
| Snippet | The invention is directed to a short term induction treatment with anti-N3pGlu Aβ antibodies of a disease characterized by deposition of Aβ in the brain, that... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | ANTI-N3PGLU AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230719&DB=EPODOC&locale=&CC=EP&NR=3478712B1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LmB3mQvhVtm3YrOKRtUjdZPxitzKfRdinspRuu4r_vpWzTF307knBcQn73keQuAPc00_uLga6pmlkIlRqlreZZ31Sp0AfSwKLRk9nIQWiNUvo6M2ctWO5yYZo6oV9NcUREVIF4rxt9vf45xGLN28rNQ77EptWznwyZso2O5atmRCBzhzyOWOQpnoeUEk5RWePO1HQXA6UD6UXLMvv8zZVJKevfFsU_hcMYmVX1GbRE1YFjb_fxWgeOgu19N5Jb6G3O4ckJk7EaGvHLJCVO8D6Jxoy4PHFIzONkzDiRA9xI-ndIMpKipiTJiE955F8A8XnijVQUY76f8pzHe4GNS2hXq0pcyfxqWT7GtBBDJaWllfeLx0VWZLaplzkVWhe6f7Lp_dN3DSdy7eSRpWbfQLv--BS3aGvr_K5ZpW-jMHza |
| link.rule.ids | 230,309,786,891,25594,76906 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsX5mQfZW9F2abuBQ9YmtdV-MTKZT6PtWthLN1zFf99L2aYv-nYk4biE_O4jyV0A7miimfO-piqqnuUK7RUDJU1MXaG51pcGFo2ezEYOQsOd0JepPm3AYpsLU9cJ_aqLIyKiMsR7Vevr1c8hFqvfVq7v0wU2LZ8cMWTdTXQsXzUjApk15HHEIrtr20h1wzEqa9yZqmZhoLRnyuK80nN6s2RSyuq3RXGOYD9GZmV1DI28bEPL3n681oaDYHPfjeQGeusTeByFwlPCXvzsT8goePcjjxGLixGJeSw8xokcYEXSv0OSkQlqSiJcPuaRcwrE4cJ2FRRjtpvyjMc7gXtn0CyXZX4u86tl-RjdQAwVlBZGamYP8yRLBrpWpDRXO9D5k83FP3230HJF4M98L3y9hEO5jvL4Uh1cQbP6-Myv0e5W6U29Yt-h6X_H |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ANTI-N3PGLU+AMYLOID+BETA+PEPTIDE+ANTIBODIES+AND+USES+THEREOF&rft.inventor=IRIZARRY%2C+Michael+Carl&rft.inventor=DEMATTOS%2C+Ronald+Bradley&rft.date=2023-07-19&rft.externalDBID=B1&rft.externalDocID=EP3478712B1 |